What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2023-03-29 compared with 2022-03-23 · 26 added, 28 removed, 77 unchanged (41% of the section changed)

40 unchanged sentences

See Index to Exhibits below.

of Incorporation, as amended

and Restated Bylaws

of Capital Stock

Certificate of Incorporation, as amended

Certificate of Amendment to the Certificate of Incorporation

Amended and Restated Bylaws

Description of Capital Stock

2015 Equity Incentive Plan*

to 2015 Equity Incentive Plan*

Lee Employment Agreement*

to Sam Lee Employment Agreement*

Martin Consulting Agreement*

Financial Officer Offer Letter dated May 26, 2017 - James Martin*

of Underwriter’s Warrant

License and Research Collaboration Agreement between the Company and Merck Sharp & Dohme Corp., dated January 2, 2019***

Agency Agreement, dated January 29, 2020

of Securities Purchase Agreement**

Letter, dated February 26, 2020

of Securities Purchase Agreement, dated February 27, 2020**

of Securities Purchase Agreement, dated March 9, 2020**

Agreement, dated February 18, 2020, between the Company and Kansas State University Research Foundation****

Agreement, dated April 19, 2020, between the Company and Kansas State University Research Foundation****

At-The-Market

Offering Agreement, dated July 1, 2020, by and between the Company and H.C.

Amendment to 2015 Equity Incentive Plan*

Sam Lee Employment Agreement*

Amendment to Sam Lee Employment Agreement*

James Martin Consulting Agreement*

Chief Financial Officer Offer Letter dated May 26, 2017 - James Martin*

Form of Underwriter’s Warrant

Exclusive License and Research Collaboration Agreement between the Company and Merck Sharp & Dohme Corp., dated January 2, 2019***

Placement Agency Agreement, dated January 29, 2020

Form of Securities Purchase Agreement**

Engagement Letter, dated February 26, 2020

Form of Securities Purchase Agreement, dated February 27, 2020**

Form of Securities Purchase Agreement, dated March 9, 2020**

License Agreement, dated February 18, 2020, between the Company and Kansas State University Research Foundation****

License Agreement, dated April 19, 2020, between the Company and Kansas State University Research Foundation****

At-The-Market Offering Agreement, dated July 1, 2020, by and between the Company and H.C.

Wainwright & Co., LLC

Agreement, dated as of May 4, 2021 by and between Cocrystal Pharma, Inc.

Underwriting Agreement, dated as of May 4, 2021 by and between Cocrystal Pharma, Inc.

Wainwright & Co., LLC**

and Scientific Advisory Board Agreement, dated April 13, 2021 with Roger Kornberg

of Weinberg & Company

Certification

of Principal Executive Officer (302)

Certification

of Principal Executive Officer (302)

Consulting and Scientific Advisory Board Agreement, dated April 13, 2021 with Roger Kornberg

Consent of Weinberg & Company

Certification of Principal Executive Officer (302)

Certification of Principal Financial Officer (302)

17 unchanged sentences

Item 601 of Regulation S-K.

of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders

of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders

who make a written request to our Corporate Secretary at Cocrystal Pharma, Inc., 19805 N.

13 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures